Berlin Hall Educational session

HER2 and beyond: The role for antibody drug conjugates (ADCs) in HER2 non overexpressing breast cancers (ID 1)

Date
Thu, 11.05.2023
Time
16:45 - 18:15
Room
Berlin Hall
Chairs
  • Heather L. McArthur (Dallas, TX, United States of America)
HER2 and beyond: The role for antibody drug conjugates (ADCs) in HER2 non overexpressing breast cancers

Clinical impact of evolving ADC technology (ID 1)

Lecture Time
16:45 - 17:05
Session Name
HER2 and beyond: The role for antibody drug conjugates (ADCs) in HER2 non overexpressing breast cancers
Room
Berlin Hall
Date
Thu, 11.05.2023
Time
16:45 - 18:15
Speakers
  • Heather L. McArthur (Dallas, TX, United States of America)
Authors
  • Heather L. McArthur (Dallas, TX, United States of America)
HER2 and beyond: The role for antibody drug conjugates (ADCs) in HER2 non overexpressing breast cancers

Current ADC landscape (ID 2)

Lecture Time
17:05 - 17:25
Session Name
HER2 and beyond: The role for antibody drug conjugates (ADCs) in HER2 non overexpressing breast cancers
Room
Berlin Hall
Date
Thu, 11.05.2023
Time
16:45 - 18:15
Speakers
  • Veronique C. Dieras (Rennes, France)
Authors
  • Veronique C. Dieras (Rennes, France)
  • Hope S. Rugo (San Francisco, CA, United States of America)
HER2 and beyond: The role for antibody drug conjugates (ADCs) in HER2 non overexpressing breast cancers

Emerging toxicities and management strategies (ID 3)

Lecture Time
17:25 - 17:45
Session Name
HER2 and beyond: The role for antibody drug conjugates (ADCs) in HER2 non overexpressing breast cancers
Room
Berlin Hall
Date
Thu, 11.05.2023
Time
16:45 - 18:15
Speakers
  • Sung-Bae Kim (Seoul, Korea, Republic of)
Authors
  • Sung-Bae Kim (Seoul, Korea, Republic of)
HER2 and beyond: The role for antibody drug conjugates (ADCs) in HER2 non overexpressing breast cancers

Future directions for ADCs (ID 4)

Lecture Time
17:45 - 18:05
Session Name
HER2 and beyond: The role for antibody drug conjugates (ADCs) in HER2 non overexpressing breast cancers
Room
Berlin Hall
Date
Thu, 11.05.2023
Time
16:45 - 18:15
Speakers
  • Javier Cortes (Madrid and Barcelona, Spain)
Authors
  • Javier Cortes (Madrid and Barcelona, Spain)
HER2 and beyond: The role for antibody drug conjugates (ADCs) in HER2 non overexpressing breast cancers

Q&A and discussion (ID 5)

Lecture Time
18:05 - 18:15
Session Name
HER2 and beyond: The role for antibody drug conjugates (ADCs) in HER2 non overexpressing breast cancers
Room
Berlin Hall
Date
Thu, 11.05.2023
Time
16:45 - 18:15
Speakers
  • To be Announced (Barcelona, Spain)
Authors
  • To be Announced (Barcelona, Spain)